Tats...QUOTE..."Cost and side effects will not stop GLP-1 drugs from absolutely destroying V sales in the AD space"...
You must be kidding...Cost and Side effects always matter a great deal....Also, having AD stokes much more fear in patients than the fear of being overweight or diabetic.....I know because I have both relatives in my family, who are diabetic and overweight plus relatives, who have Alzheimers.
Diabetes and overweight are a nuisance...Alzheimers is a curse.
Incidentally, Diabetes and overweight are factors known to induce CVD...Vascepa has been proven to help with those also.